Back to top
more

Rockwell Medical (RMTI)

(Real Time Quote from BATS)

$2.11 USD

2.11
454,636

+0.34 (19.21%)

Updated Aug 8, 2024 01:34 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (86 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for RMTI

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

Rockwell Medical, Inc. [RMTI]

Reports for Purchase

Showing records 181 - 200 ( 241 total )

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 181

10/22/2018

Company Report

Pages: 7

CMS and Proposed Rule Changes: What to Expect

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 182

10/18/2018

Company Report

Pages: 10

Updated Analysis for Rockwell After This Week?s News Flow - A Dense Onion to Unpeel

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 183

10/12/2018

Company Report

Pages: 7

Update on NDA for IV form of Triferic

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 184

10/05/2018

Company Report

Pages: 11

What?s the new CEO thinking? Our conversations with Stuart Paul.

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 185

08/15/2018

Company Report

Pages: 8

Rockwell Reports Q2 Results and Restated Q1 Items - Key Points

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 186

08/08/2018

Company Report

Pages: 8

Rockwell Medical Names New CEO - Time To Move On Part II

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 187

08/06/2018

Company Report

Pages: 8

Rockwell Medical and Former Leadership Reach a Settlement - Time To Move On.

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 188

08/03/2018

Company Report

Pages: 7

Clears Up Timeline for Second Quarter Earnings Report - Job Well Done

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 189

07/30/2018

Company Report

Pages: 7

New Auditor Has Been Engaged.

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 190

07/16/2018

Company Report

Pages: 7

Finally, One in the Win Column!! Calcitriol gets FDA Approval Earlier than Expected.

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 191

06/28/2018

Company Report

Pages: 11

CMMI Fails Dialysis Patients - Can?t Be Bothered to Evaluate Innovative Drug Triferic?

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 192

06/21/2018

Company Report

Pages: 7

Rockwell and Former CEO Reach Term Sheet Agreement - What Does It Mean?

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 193

06/07/2018

Company Report

Pages: 7

We are reiterating our Strong Buy recommendation

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 194

05/30/2018

Company Report

Pages: 7

Circuit Court Solves Uncertainty for Now ? CEO Rob Chioini and CFO Tom Klema are Out.

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 195

05/23/2018

Company Report

Pages: 7

Update on Termination of CEO Rob Chioini and CFO Tom Klema

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 196

05/23/2018

Company Report

Pages: 8

Rockwell Medical Announces Termination of CEO Rob Chioini

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 197

05/11/2018

Company Report

Pages: 9

Presents Financial Results from 1Q2018 and Update on Company Events

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 198

05/09/2018

Company Report

Pages: 7

Updates Progress and Timeline for FDA Review of Calcitriol

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 199

03/16/2018

Company Report

Pages: 10

Financial Results from 4Q and FY2017 and Update on Company Events

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party

Company: Rockwell Medical, Inc.

Industry: Medical - Products

Record: 200

11/09/2017

Company Report

Pages: 9

Third Quarter Financial Results In-Line, Confidence in Triferic and Calcitriol Launches is High.

Provider: IFS Securities, Inc.

Analyst: BOUCHEY D

Price: 25.00

Research Provided by a Third Party
// eof